High blood sugar in a hospital is not treated with a single magic injection and a stern lecture about dessert. Hospital hyperglycemia can develop because of diabetes, infection, surgery, physical stress, steroid medications, interrupted nutrition, or a previously undiagnosed glucose disorder. Treatment therefore depends on much more than one number flashing on a glucose meter.
Hospital teams first determine how severe the hyperglycemia is, whether the patient is critically ill, and whether a dangerous emergency such as diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS) is present. They then combine glucose monitoring, insulin, fluids, electrolyte management, nutrition planning, and treatment of the underlying illness.
Current American Diabetes Association guidance defines hospital hyperglycemia as a blood glucose level above 140 mg/dL. For most hospitalized adults, medication is started or intensified when glucose remains at or above 180 mg/dL, although the exact plan is personalized. The goal is controlled, steady improvementnot a glucose roller coaster with a dramatic plunge into hypoglycemia.
Why Does Blood Sugar Rise During Hospitalization?
A patient does not need to arrive with uncontrolled diabetes to develop high blood sugar in the hospital. Acute illness activates stress hormones such as cortisol and adrenaline. These hormones help the body respond to danger, but they also encourage the liver to release glucose and make cells less responsive to insulin.
Common hospital-related causes include:
- Infections, pneumonia, sepsis, heart attacks, strokes, or major injuries
- Surgery and the body’s stress response to an operation
- Glucocorticoids such as prednisone or dexamethasone
- Tube feeding, intravenous nutrition, or changing meal schedules
- Missed, delayed, or reduced diabetes medication
- Kidney or liver dysfunction that complicates medication dosing
- Previously undiagnosed diabetes
This temporary rise is sometimes called stress hyperglycemia. An A1C test may be ordered if no recent result is available. Because A1C reflects average glucose over roughly the previous two to three months, it can help clinicians decide whether the problem likely existed before admission or appeared during the current illness.
What Happens During the Initial Evaluation?
The first step is not simply “give insulin.” Clinicians evaluate the entire situation, including symptoms, vital signs, medical history, home medications, recent food intake, kidney function, hydration, and the reason for hospitalization.
Blood glucose confirmation
A bedside finger-stick test provides a rapid result, while a laboratory blood sample may be used for confirmation or more detailed evaluation. Glucose may then be checked before meals and at bedtime. A patient who is not eating may be tested every four to six hours, while someone receiving intravenous insulin may need hourly checks.
Laboratory testing
Depending on severity, the medical team may order tests for:
- Electrolytes, especially potassium and sodium
- Kidney function
- Blood or urine ketones
- Blood acidity and bicarbonate
- Serum osmolality
- A1C
- Signs of infection or another triggering illness
Confusion, deep or rapid breathing, vomiting, abdominal pain, severe weakness, profound dehydration, or a fruity odor on the breath can point toward a hyperglycemic emergency. DKA and HHS require urgent treatment and close monitoring.
What Blood Sugar Range Do Hospitals Target?
The safest target depends on the patient’s condition. For most noncritically ill adults, current guidance recommends a glucose range of approximately 100 to 180 mg/dL, provided that it can be reached without causing significant hypoglycemia. For many critically ill patients in an intensive care unit, a target of 140 to 180 mg/dL is commonly used.
Doctors generally avoid forcing glucose into a perfectly normal fasting range during serious illness. Trials of very tight inpatient glucose control found that aggressive insulin treatment could produce dangerous hypoglycemia. In the hospital, “lower” is not automatically “better.” Safe, predictable, and moderately controlled usually wins the trophy.
Insulin Is the Main Hospital Treatment
Insulin is widely used because it works quickly, can be adjusted frequently, and remains effective even when illness changes a patient’s usual insulin requirements. A home diabetes routine may therefore be temporarily replaced or modified during hospitalization.
Intravenous insulin in critical illness
Patients in an ICU, those undergoing certain major procedures, and people with DKA or HHS may receive insulin continuously through an intravenous line. An IV infusion allows the dose to be changed rapidly according to a hospital protocol.
Because IV insulin acts quickly, glucose must be monitored frequently. Nurses may check it every hour until it becomes stable. The infusion rate is adjusted according to the current glucose level, the direction in which it is moving, nutrition, medications, and the patient’s response.
Subcutaneous insulin outside the ICU
Stable patients on a regular hospital floor usually receive insulin under the skin. A typical scheduled plan may include three components:
- Basal insulin: Long-acting insulin that covers glucose production between meals and overnight.
- Prandial insulin: Rapid-acting insulin given for carbohydrates consumed with meals.
- Correction insulin: An additional dose used when glucose is above the target range.
This is called a basal-bolus-correction regimen. The doses can be adjusted daily as appetite, kidney function, steroid treatment, infection, and physical activity change.
Why sliding-scale insulin alone is discouraged
Traditional sliding-scale treatment waits until glucose is already high and then reacts with short-acting insulin. Used by itself, this approach does not provide steady background coverage and may create repeated highs and lows.
Correction insulin still has a useful role, but it is usually combined with scheduled insulin when hyperglycemia persists. Endocrine Society guidance allows correction-only treatment initially in selected patients with newly recognized or mild hyperglycemia. If two or more readings reach at least 180 mg/dL within 24 hours, scheduled insulin is generally added.
Special importance of basal insulin in type 1 diabetes
People with type 1 diabetes need basal insulin even when they are fasting, nauseated, or scheduled for surgery. Completely stopping insulin can allow ketones and DKA to develop. Meal insulin may be reduced or withheld when no food is eaten, but basal coverage generally continues with carefully adjusted dosing.
Are Oral and Noninsulin Diabetes Medications Continued?
Sometimesbut not always. Many hospitals temporarily hold certain outpatient medications because acute illness changes their safety profile.
For example, a medication may be paused when a patient:
- Cannot eat reliably
- Has worsening kidney or liver function
- Is dehydrated or has low blood pressure
- Is undergoing surgery or a procedure
- May receive contrast material
- Has an increased risk of lactic acidosis, ketoacidosis, or hypoglycemia
SGLT2 inhibitors are generally avoided during severe illness, prolonged fasting, and major surgery because they can contribute to ketoacidosis, sometimes even when glucose is not dramatically elevated. Sulfonylureas may cause prolonged hypoglycemia when appetite or kidney function is unpredictable.
Selected stable patients with mild type 2 diabetes-related hyperglycemia may receive a DPP-4 inhibitor with correction insulin. However, scheduled insulin remains the preferred approach for most hospitalized adults with persistent or more substantial hyperglycemia.
How Are Steroid-Related Highs Treated?
Glucocorticoids are excellent at reducing inflammation and equally talented at annoying the glucose meter. Prednisone, methylprednisolone, and dexamethasone can produce substantial hyperglycemia, even in patients without known diabetes.
The pattern depends on the steroid and when it is administered. Morning prednisone, for example, may cause the largest glucose rise later in the day. Clinicians may use basal-bolus insulin or NPH insulin timed to better match the steroid’s glucose-raising effect.
Frequent reassessment is essential. When steroids are reduced or discontinued, insulin requirements may fall quickly. Without prompt dose adjustment, yesterday’s helpful insulin dose can become today’s hypoglycemia problem.
How Are Tube Feeding and IV Nutrition Managed?
Continuous tube feeding delivers carbohydrates around the clock, so insulin coverage must be synchronized with the feeding schedule. Hospitals may use basal-bolus insulin, regularly scheduled short-acting insulin, or an NPH-based plan.
The greatest safety concern occurs when nutrition stops unexpectedly but insulin continues working. Hospitals use interruption protocols that may involve holding nutritional insulin, increasing glucose checks, or providing dextrose until the insulin effect diminishes.
Total parenteral nutrition, which supplies nutrients through a vein, can also cause hyperglycemia. Insulin may be administered separately or, in selected settings, added to the nutrition solution under pharmacy and clinical supervision.
How Are DKA and HHS Treated?
DKA and HHS are medical emergencies, not “drink some water and check again later” situations. Both can cause severe dehydration, electrolyte disturbances, altered mental status, organ dysfunction, coma, and death.
Intravenous fluids
Treatment usually begins with IV fluids to restore circulation and replace water lost through excessive urination. Fluid type and speed are adjusted for age, blood pressure, sodium level, heart function, kidney function, and the severity of dehydration.
Potassium and other electrolytes
Total body potassium is often depleted even when the first blood test shows a normal or high potassium level. As fluids and insulin begin working, potassium moves back into cells and the blood level can fall rapidly.
Potassium is therefore checked repeatedly and replaced when appropriate. If it is dangerously low, insulin may be delayed briefly while potassium is corrected because severe hypokalemia can trigger abnormal heart rhythms and muscle weakness.
Insulin therapy
IV insulin stops ketone production in DKA and gradually lowers glucose in both DKA and HHS. When glucose falls before the acidosis or ketosis has fully resolved, dextrose may be added to IV fluids so insulin can continue safely.
Treating the trigger
The team also looks for the event that caused the crisis. Common triggers include infection, a missed insulin dose, pump failure, heart attack, stroke, medication changes, or a new diagnosis of diabetes.
HHS generally requires especially careful correction because glucose and osmolality may be extremely high. The medical team avoids dropping them too rapidly, which could create harmful fluid shifts. The central pillars remain fluids, insulin, electrolyte replacement, and treatment of the underlying cause.
How Do Hospitals Prevent Hypoglycemia?
Insulin is considered a high-alert medication because dosing mistakes can cause serious harm. Hospitals use standardized order sets, electronic alerts, independent dose checks, meal coordination, and monitoring protocols to reduce risk.
The insulin plan may be adjusted when:
- A meal is missed or delayed
- Tube feeding is interrupted
- Kidney function worsens
- Steroid doses are tapered
- Nausea or appetite changes
- The patient becomes more active
- Glucose begins trending below the target range
A reading below 70 mg/dL usually triggers a hospital hypoglycemia protocol. Treatment may include oral fast-acting carbohydrate, intravenous dextrose, or glucagon, depending on the patient’s condition. The insulin regimen is then reviewed rather than sending everyone back onto the same metabolic amusement-park ride.
Can Patients Keep Using a CGM or Insulin Pump?
Some patients can continue using a continuous glucose monitor, insulin pump, or hybrid closed-loop system during a noncritical hospital stay. This depends on the patient’s mental and physical ability to manage the device, hospital policies, available supplies, staff expertise, and whether procedures will interfere with the equipment.
Pump self-management is generally inappropriate during DKA, HHS, critical illness, impaired consciousness, or any condition that prevents safe device operation. Even when a CGM remains in place, confirmatory bedside glucose testing may be required before insulin decisions are made.
Hospitals should document pump doses, establish backup insulin plans, and specify how devices will be managed during imaging, anesthesia, and surgery.
Transitioning From IV Insulin to Injections
Once a critically ill patient improves, the team may switch from an insulin infusion to subcutaneous insulin. This requires planning because IV insulin disappears from the bloodstream within minutes, while long-acting insulin needs time to begin working.
Basal insulin is usually administered before the infusion is stopped so that the treatments overlap. The new total daily dose may be estimated from recent IV insulin requirements, previous outpatient doses, body weight, nutrition, kidney function, and the resolving illness.
Stopping an infusion without adequate basal coverage can cause rebound hyperglycemia and, in insulin-deficient patients, renewed ketone production. A safe transition is more like passing a baton than dropping one and hoping the next runner notices.
What Happens Before Discharge?
Hospital treatment is not complete when the last elevated reading disappears. Discharge planning should answer several practical questions:
- Was the high glucose temporary or evidence of diabetes?
- Which home medications should be restarted, stopped, or changed?
- Does the patient understand the new insulin dose and device?
- Are a glucose meter, strips, needles, insulin, and ketone supplies available?
- Can the patient afford and obtain the prescribed treatment?
- When should glucose be checked?
- What symptoms require an urgent call or emergency care?
- Has a follow-up appointment been scheduled?
Patients starting insulin should receive hands-on education about injection technique, dose timing, glucose monitoring, hypoglycemia treatment, and sick-day management. Medication reconciliation is particularly important because a confusing switch between pens, vials, concentrations, or dosing schedules can produce major errors after discharge.
Follow-up is often needed within several weeks and sooner when treatment changed substantially, glucose remains unstable, or access to medication is uncertain. Inpatient diabetes education and coordinated follow-up may improve control and reduce avoidable readmissions.
A Realistic Hospital Experience: What the Process May Feel Like
The following is a fictional composite based on common hospital workflows rather than the story of a specific patient.
Imagine that Michael, a 58-year-old man with type 2 diabetes, arrives at the emergency department with pneumonia. His blood glucose is 326 mg/dL, much higher than his usual home readings. He is dehydrated, breathing rapidly, and has barely eaten since the previous morning.
The care team checks another glucose level, kidney function, electrolytes, A1C, and ketones. His ketones are not substantially elevated, and he does not have the acidosis required for a DKA diagnosis. His A1C, however, is above his usual goal, suggesting that the infection is worsening an existing glucose-control problem rather than creating an entirely temporary one.
Michael’s home metformin is paused because he is acutely ill and dehydrated. He receives IV fluids and antibiotics for pneumonia. A nurse checks his glucose before meals and at bedtime. Because several readings remain above 180 mg/dL, the hospitalist starts a basal-bolus-correction insulin plan.
On the first evening, Michael does not understand why he needs insulin when he normally takes pills. The nurse explains that insulin is easier to adjust during an unpredictable illness. It does not necessarily mean that he will need injections forever. That clarification matters; without it, a temporary hospital treatment can feel like a permanent and rather unwelcome plot twist.
The next morning, Michael receives a steroid to reduce airway inflammation. His lunchtime glucose is acceptable, but his afternoon reading rises sharply. Instead of assuming that he secretly ordered a birthday cake, the team recognizes the typical steroid-related pattern and adjusts his insulin coverage.
On day three, his appetite improves, the IV fluids are stopped, and his infection begins responding to treatment. His glucose values decline. Because the steroid dose is also being reduced, the medical team lowers his insulin to prevent hypoglycemia.
Before discharge, a diabetes educator reviews his glucose meter, medications, meal planning, sick-day rules, and warning signs. Michael practices using an insulin pen because he will need a small basal dose temporarily. The pharmacist confirms that his insurance covers the prescribed pen and needles. The discharge instructions clearly state which previous medications to restart and which dose replaces the hospital regimen.
Michael is told to contact his clinician for repeated readings above the specified threshold, low readings, vomiting, inability to keep fluids down, breathing trouble, or ketones. A follow-up appointment is arranged rather than leaving him with the classic discharge strategy of “good luck and please decipher these six pages of tiny print.”
This example shows why inpatient hyperglycemia treatment changes from day to day. The infection, hydration level, medications, food intake, and recovery process all influence insulin needs. Successful care is not simply lowering one number. It is safely matching treatment to a moving clinical target while preparing the patient to manage the next stage at home.
Conclusion
Hospital hyperglycemia is treated through structured monitoring, individualized glucose targets, insulin therapy, nutrition coordination, and correction of the illness or medication effect driving the high readings. Stable patients often receive scheduled subcutaneous insulin, while critically ill patients and those with DKA or HHS may require IV insulin, fluids, and intensive electrolyte monitoring.
The goal is not instant perfection. It is controlled improvement without dangerous hypoglycemia, followed by a safe transition to an understandable and affordable outpatient plan. Because insulin needs can change quickly as infection resolves, steroids are tapered, or nutrition resumes, hospital treatment is continuously reassessed.